Unveiling the Significance of LysE in Survival and Virulence of Mycobacterium tuberculosis: A Review Reveals It as a Potential Drug Target, Diagnostic Marker, and a Vaccine Candidate

Author:

Upadhyay Shilpa1ORCID,Dhok Archana2,Kashikar Supriya3,Quazi Zahiruddin Syed4ORCID,Agarkar Vinod B.3ORCID

Affiliation:

1. Global Consortium of Public Health Research, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha 442107, Maharashtra, India

2. i-Health Consortium, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha 442107, Maharashtra, India

3. GeNext Genomics Pvt. Ltd., Nagpur 440010, Maharashtra, India

4. Global Evidence Synthesis Initiative, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha 442107, Maharashtra, India

Abstract

Tuberculosis (TB) remains a global health threat, necessitating innovative strategies for control and prevention. This comprehensive review explores the Mycobacterium tuberculosis Lysine Exporter (LysE) gene, unveiling its multifaceted roles and potential uses in controlling and preventing tuberculosis (TB). As a pivotal player in eliminating excess L-lysine and L-arginine, LysE contributes to the survival and virulence of M. tuberculosis. This review synthesizes findings from different electronic databases and includes 13 studies focused on the LysE of M. tuberculosis. The research unveils that LysE can be a potential drug target, a diagnostic marker for TB, and a promising candidate for vaccine development. The absence of LysE in the widely used BCG vaccine underscores its uniqueness and positions it as a novel area for TB prevention. In conclusion, this review underscores the significance of LysE in TB pathogenesis and its potential as a drug target, diagnostic marker, and vaccine candidate. The multifaceted nature of LysE positions it at the forefront of innovative approaches to combat TB, calling for sustained research efforts to harness its full potential in the global fight against this infectious disease.

Publisher

MDPI AG

Reference38 articles.

1. World Health Organization (2024, June 11). Global Tuberculosis Report 2021. Available online: https://iris.who.int/bitstream/handle/10665/346387/9789240037021-eng.pdf?sequence=1.

2. World Health Organization (2024, June 11). Global Tuberculosis Report 2022. Available online: https://iris.who.int/bitstream/handle/10665/363752/9789240061729-eng.pdf?sequence=1.

3. World Health Organization (2024, June 11). Tuberculosis: Key Facts, Available online: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.

4. World Health Organization (2023). Global Tuberculosis Report 2023, WHO.

5. Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019;Bu;Front. Pharmacol.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3